Peiyi Xie

机构：Sun Yat-sen University, Fudan University, Sixth Affiliated Hospital of Sun Yat-sen University, Zhongshan Hospital, Ministry of Education · ORCID：0000-0001-5130-1506

发表论文 58 篇 · 总被引 1073 次 · h-index 17

代表论文

• CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 65)
• ACE2 Enhances Sensitivity to PD-L1 Blockade by Inhibiting Macrophage-Induced Immunosuppression and Angiogenesis (2024 · Cancer Research · 被引 33)
• FMO2 + cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 22)
• Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective study (2024 · European Radiology · 被引 18)
• The deubiquitinating enzyme USP44 suppresses hepatocellular carcinoma progression by inhibiting Hedgehog signaling and PDL1 expression (2023 · Cell Death and Disease · 被引 15)
• Diagnostic CT of colorectal cancer with artificial intelligence iterative reconstruction: A clinical evaluation (2024 · European Journal of Radiology · 被引 14)